Temporal Trends and Mortality of Vancomycin-Resistant Enterococcus Bacteremia—A Six-Year Retrospective Cohort Study in a Tertiary Hospital in Greece
Pathogens · 2026
DOI: 10.3390/pathogens15050467 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Pathogens, 2026. Verfasst von Despoina Kypraiou und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, University of Crete, 71003 Heraklion, Greece. Hauptthemen laut MEDLINE: Bacteremia, Vancomycin-Resistant Enterococci, Gram-Positive Bacterial Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Region of Crete.
Abstract (Originalsprache)
Background
Vancomycin-resistant Enterococcus (VRE) bacteremia represents a major therapeutic and epidemiological challenge, particularly in regions with high antimicrobial resistance rates such as Southern Europe. Longitudinal local data are essential to guide infection control and antimicrobial stewardship strategies. This study aimed to evaluate temporal trends in incidence, management, and mortality of VRE bacteremia in a tertiary care center in Greece over a six-year period, including comparison before and after the coronavirus disease 2019 (COVID-19) pandemic.
Methods
This retrospective observational study included adult patients with VRE bacteremia at the University Hospital of Heraklion, Greece, from 2018 to 2023. Demographic and clinical data, such as the Pitt Bacteremia Index (PBI), as well as microbiological, and treatment data were collected from patient records. Incidence was calculated per 10,000 patient-days. Comparisons were performed between survivors and non-survivors and between pre- and post-COVID-19 eras. Multivariate regression analysis was used to identify predictors of in-hospital mortality.
Results
A total of 96 patients were included (mean age 68.6 ± 14.5 years; 56.3% male). The incidence of VRE bacteremia increased more than five-fold during the study period, from 0.242 cases per 10,000 patient-days in 2018 to a peak of 1.344 per 10,000 patient-days in 2022, remaining elevated in 2023 (1.001 per 10,000 patient-days). The overall in-hospital mortality was 54.2%. Non-survivors had significantly higher PBI scores compared to survivors (median 2.5 vs. 0, p = 0.005). In the multivariate analysis, higher PBI was independently associated with in-hospital mortality [odds ratio: 1.449 (95% confidence intervals: 1.166–1.801)]. Appropriate empirical therapy was administered in 41.7% of cases and was not significantly associated with survival. Post-COVID-19 patients were older (69.9 vs. 61.4 years, p = 0.0365), and antimicrobial regimens were more frequently adjusted according to susceptibility testing (55.7% vs. 18.2%, p = 0.0141), but mortality did not significantly differ between periods.
Conclusion
VRE bacteremia incidence increased dramatically over the six-year study period in our tertiary center, with persistently high mortality exceeding 50%. Severity of illness at the diagnosis of bacteremia, as measured by the PBI, was an independent predictor of in-hospital mortality. Strengthened infection prevention measures, optimized antimicrobial stewardship, and early aggressive management are urgently needed to mitigate the growing burden of VRE bacteremia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, University of Crete, 71003 Heraklion, Greece.
- Internal Medicine Department, University Hospital of Heraklion, 71110 Heraklion, Greece.
- Infection Control Committee, University Hospital of Heraklion, 71110 Heraklion, Greece.
- Clinical Microbiology Laboratory, University Hospital of Heraklion, 71110 Heraklion, Greece.
ORCID-Profile: Despoina Kypraiou, Angelos Sourris, Eirini Astrinaki, Kyriaki Tryfinopoulou, Petros Ioannou, Diamantis Kofteridis
Förderung
- Region of Crete
Zitieren
APA
Kypraiou, D., Sourris, A., Astrinaki, E., Vitsaxaki, E., Saplamidou, S., Vakonaki, M., Tryfinopoulou, K., Chamilos, G., Ioannou, P., & Kofteridis, D. (2026). Temporal Trends and Mortality of Vancomycin-Resistant Enterococcus Bacteremia—A Six-Year Retrospective Cohort Study in a Tertiary Hospital in Greece. Pathogens. https://doi.org/10.3390/pathogens15050467
Vancouver
Kypraiou D, Sourris A, Astrinaki E, Vitsaxaki E, Saplamidou S, Vakonaki M, et al. Temporal Trends and Mortality of Vancomycin-Resistant Enterococcus Bacteremia—A Six-Year Retrospective Cohort Study in a Tertiary Hospital in Greece. Pathogens. 2026. doi:10.3390/pathogens15050467
BibTeX
@article{Kypraiou2026,
author = {Kypraiou, Despoina and Sourris, Angelos and Astrinaki, Eirini and Vitsaxaki, Efsevia and Saplamidou, Stamatina and Vakonaki, Maria and Tryfinopoulou, Kyriaki and Chamilos, Georgios and Ioannou, Petros and Kofteridis, Diamantis},
title = {Temporal Trends and Mortality of Vancomycin-Resistant Enterococcus Bacteremia—A Six-Year Retrospective Cohort Study in a Tertiary Hospital in Greece},
journal = {Pathogens},
year = {2026},
doi = {10.3390/pathogens15050467}
}
EUVIMED